BIOTRONIK in the news
Medical technology innovation and solutions
Tamtam found 20 recent articles about BIOTRONIK.
- Syensqo: PSU für Herzschrittmacher-Header
Syensqo's PSU material enhances Biotronik's Amvia Sky pacemaker with biocompatibility, transparency, and mechanical strength, supporting advanced cardiac device features.
- Teleflex (TFX): Evaluating Valuation After BIOTRONIK Deal and Recent Share Price Rebound
Teleflex's recent BIOTRONIK acquisition is expected to boost growth and earnings, but stock remains down with risks from integration and product challenges.
- Patient Eins: Biotronik testet PFA-Katheter ohne Repositionierung
Biotronik is testing its ElePulse pulsed-field ablation catheter that isolates pulmonary veins without repositioning, showing promising initial clinical results for atrial fibrillation treatment.
- First patient enrolled in RESET-AF 3D study of Biotronik’s novel pulsed field ablation system
Biotronik has begun a clinical study of its Elepulse pulsed field ablation system for atrial fibrillation, showing promising initial results and aiming for CE-mark approval.
- Biotronik selects Syensqo’s Eviva Polysulfone for pacemaker header components
BIOTRONIK uses Syensqo’s Eviva Polysulfone for pacemaker headers due to its biocompatibility and transparency aiding precise implantation.
- Lake Oswego medical device company faces new allegations of fraud, ‘kickbacks’
Biotronik is sued by a former sales director alleging illegal kickbacks, Medicare fraud, and retaliation over defective heart-monitoring devices.
- 9th Circ. Won't Rehear Biotronik Whistleblower Revival
The 9th Circuit refused to rehear a whistleblower case involving Biotronik, a medical technology firm.
- Digitale Innovationen für Herzpatienten
Biotronik and the University of Sydney collaborate to develop digital tools using AI and telemonitoring to enhance cardiovascular care, especially for underserved patients.
- Kooperation zu digitalen Herzmedizin-Lösungen
A partnership is developing and testing digital heart health tools using telemonitoring and AI to improve care for cardiovascular patients.
- Biotronik implantiert weltweit erstes CRT-D-Gerät für LBBAP-Verfahren
Biotronik completed the first global implantation of a CRT-D device for LBBAP, advancing heart rhythm therapy with a new device series undergoing clinical trials.
- Erste Implantation eines CRT-D-Systems für LBBAP-Stimulation
A new CRT-D system for LBBAP was first implanted in Australia as part of a study to assess its safety and effectiveness in improving heart muscle activation.
- Biotronik Wants Full 9th Circ. Review Of Whistleblower Ruling
Biotronik seeks full Ninth Circuit review of a whistleblower lawsuit alleging unlawful sales compensation tactics.
- Biotronik announces first procedure involving CRT-D implant developed for LBBA pacing
Biotronik achieved the first human implantation of a CRT-D device designed for left bundle branch area pacing, aiming to improve cardiac therapy for patients with conduction issues.
- Teleflex (TFX): Exploring Current Valuation After BIOTRONIK Vascular Intervention Acquisition
Teleflex’s recent acquisition of BIOTRONIK's Vascular Intervention business is expected to boost revenue growth and earnings, despite recent mixed stock performance and market uncertainties.
- Sunnybrook first in Canada to implant Biotronik heart monitoring device with artificial intelligence capabilities
Sunnybrook implanted BIOTRONIK's AI-enabled heart monitor to improve arrhythmia detection and patient care in Canada.
- Biotronik stellt Solia CSP S vor: Neue Herzschrittmacher-Elektrode vereinfacht CSP-Verfahren
Biotronik launched the Solia CSP S electrode, enhancing conduction system pacing by combining fixed screw and stylet-guided implantation for more efficient and precise cardiac procedures.
- Biotronik Must Again Defend Against Whistleblower’s Fraud Suit
Biotronik must defend against a whistleblower lawsuit alleging Medicare fraud via kickbacks after the Ninth Circuit revived the case.
- Biotronik launches Solia CSP S with aim of simplifying conduction system pacing procedures
Biotronik introduced Solia CSP S, a novel pacing lead designed to simplify and improve conduction system pacing procedures.
- 9th Circ. Says News Article Doesn't Doom Biotronik FCA Suit
The Ninth Circuit revived a False Claims Act lawsuit against Biotronik over alleged illicit compensation to boost cardiac device implantations.
- Biotronik A.G. v. Conor Medsystems Ireland Ltd.
The document is an archived legal case reference involving Biotronik with no detailed business or medical technology information available.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like BIOTRONIK?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies